Literature DB >> 15790705

High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma.

G Szládek1, A Juhász, G Kardos, K Szoke, T Major, I Sziklai, I Tar, I Márton, J Kónya, L Gergely, K Szarka.   

Abstract

BACKGROUND: The aetiology and factors leading to the progression of laryngeal cancer are still unclear. Although human papillomavirus (HPV) has been suggested to play a role, reports concerning the effect of HPV infection on tumour development are controversial. Recently, transfusion transmitted virus (TTV) was suggested to play a role in certain infections as a causative or coinfecting agent. AIMS: To investigate whether the development and progression of laryngeal squamous cell carcinoma is associated with coinfection with TTV and HPV.
METHODS: The prevalence of TTV and HPV was investigated using the polymerase chain reaction in tissue samples from 40 healthy individuals, 10 patients with recurrent papillomatosis, five patients with papillomatosis with malignant transformation, and 25 patients with laryngeal carcinoma. The obtained prevalence data were compared and analysed statistically.
RESULTS: In the 11 patients with carcinoma who had metastasis or relapse there was a high rate of coinfection with genogroup 1 TTV and HPV (eight of 11), whereas in the 14 without tumour progression no coinfection was found. Coinfection was associated with significantly lower tumour free survival in patients with carcinoma (p < 0.001). Furthermore, four of five patients who had papillomatosis with malignant transformation were coinfected with genogroup 1 TTV and HPV.
CONCLUSIONS: Although the nature of cooperation between HPV and TTV needs to be investigated further, coinfection with genogroup 1 TTV and HPV appears to be associated with poor clinical outcome in laryngeal cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15790705      PMCID: PMC1770630          DOI: 10.1136/jcp.2004.022103

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas.

Authors:  H Lindeberg; A Krogdahl
Journal:  Cancer Lett       Date:  1999-11-01       Impact factor: 8.679

2.  Estimates of cancer incidence and mortality in Europe in 1995.

Authors:  F Bray; R Sankila; J Ferlay; D M Parkin
Journal:  Eur J Cancer       Date:  2002-01       Impact factor: 9.162

3.  Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.

Authors:  P Koskela; T Anttila; T Bjørge; A Brunsvig; J Dillner; M Hakama; T Hakulinen; E Jellum; M Lehtinen; P Lenner; T Luostarinen; E Pukkala; P Saikku; S Thoresen; L Youngman; J Paavonen
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

4.  Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions.

Authors:  H Okamoto; M Takahashi; T Nishizawa; M Ukita; M Fukuda; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Virology       Date:  1999-07-05       Impact factor: 3.616

5.  Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.

Authors:  Elin Ringström; Edward Peters; Masayuki Hasegawa; Marshall Posner; Mei Liu; Karl T Kelsey
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

Review 6.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

7.  Higher prevalence and viral load of TT virus in saliva than in the corresponding serum: another possible transmission route and replication site of TT virus.

Authors:  X Deng; H Terunuma; R Handema; M Sakamoto; T Kitamura; M Ito; Y Akahane
Journal:  J Med Virol       Date:  2000-12       Impact factor: 2.327

8.  Analysis of the entire genomes of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants.

Authors:  Y H Peng; T Nishizawa; M Takahashi; T Ishikawa; A Yoshikawa; H Okamoto
Journal:  Arch Virol       Date:  2002       Impact factor: 2.574

9.  Heterogeneous distribution of TT virus of distinct genotypes in multiple tissues from infected humans.

Authors:  H Okamoto; T Nishizawa; M Takahashi; S Asabe; F Tsuda; A Yoshikawa
Journal:  Virology       Date:  2001-09-30       Impact factor: 3.616

10.  High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.

Authors:  Hajime Tokita; Seiyou Murai; Hiroshi Kamitsukasa; Michiyasu Yagura; Hideharu Harada; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Med Virol       Date:  2002-08       Impact factor: 2.327

View more
  6 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

Review 2.  Transfusion transmitted virus: A review on its molecular characteristics and role in medicine.

Authors:  M Irshad; Y K Joshi; Y Sharma; I Dhar
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

Review 3.  Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review.

Authors:  Tatyana Isayeva; Yufeng Li; Daniel Maswahu; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-07-03

4.  Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition.

Authors:  Emily A Kaelin; Peter T Skidmore; Paweł Łaniewski; LaRinda A Holland; Dana M Chase; Melissa M Herbst-Kralovetz; Efrem S Lim
Journal:  mSystems       Date:  2022-03-28       Impact factor: 7.324

5.  Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy.

Authors:  Daniele Lapa; Paola Del Porto; Claudia Minosse; Gianpiero D'Offizi; Andrea Antinori; Maria Rosaria Capobianchi; Ubaldo Visco-Comandini; Fiona McPhee; Anna Rosa Garbuglia; Mauro Zaccarelli
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

6.  Cloning and expression of N22 region of Torque Teno virus (TTV) genome and use of peptide in developing immunoassay for TTV antibodies.

Authors:  Dhananjay Singh Mankotia; Mohammad Irshad
Journal:  Virol J       Date:  2014-05-20       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.